Maine Medical Center Joins Two Clinical Trials Examining Potential Treatment for COVID-19
April 15, 2020
April 15, 2020
PORTLAND, Maine, April 15 -- The Maine Medical Center issued the following news release:
Maine Medical Center has joined a pair of clinical trials designed to examine the efficacy of the drug Remdesivir for treatment of moderate and severe COVID-19. The trials' Principal Investigator is David Seder, M.D., MMC's chief of critical care, and was organized under the Maine Medical Center Research Institute (MMCRI).
MMC enrolled its first patient in the study of tre . . .
Maine Medical Center has joined a pair of clinical trials designed to examine the efficacy of the drug Remdesivir for treatment of moderate and severe COVID-19. The trials' Principal Investigator is David Seder, M.D., MMC's chief of critical care, and was organized under the Maine Medical Center Research Institute (MMCRI).
MMC enrolled its first patient in the study of tre . . .